VX-787

· Janssen Infectious Diseases BVBA

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-787, covering 2014-11-04 to 2016-09-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus [Phase 2]